Presentation is loading. Please wait.

Presentation is loading. Please wait.

© Coherent market Insights. All Rights Reserved RECOMBINANT VACCINE MARKET Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis,

Similar presentations


Presentation on theme: "© Coherent market Insights. All Rights Reserved RECOMBINANT VACCINE MARKET Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis,"— Presentation transcript:

1 © Coherent market Insights. All Rights Reserved RECOMBINANT VACCINE MARKET Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017–2025 © Coherent market Insights. All Rights Reserved

2 REPORT DESCRIPTION Recombinant vaccines are produced by using recombinant-DNA technology or genetic engineering. These vaccines function on the principle of inducing the immune response for the diseases and to have the preventive measures for some of the hazardous diseases. Recombinant vaccines has significantly managed to perform as an appropriate method for treatment of various lethal diseases in animals and humans These vaccines are superior to conventional vaccines and are highly effective in treatment of diseases such as tuberculosis, malaria and HIV. Advantages of recombinant vaccines over conventional vaccine methods are expected to drive growth of the recombinant vaccines market According to World Health Organization (WHO), around 18 million fatalities were caused due to inaccessibility of treatment for their illness. It has the advantages over the conventional vaccines as it does not lead to post vaccination reaction they are safe to use and there is no need of adjuvant in such vaccines as used in conventional vaccines due to the risk of cancer through incorporation of adjuvants. Furthermore, there are various reasons that are expected to favor the growth in recombinant vaccines market such as increase in incidence of zoonotic diseases, opportunities in the disease related to poultry facilities. The emerging technologies in recombinant vaccines which will help to treat the diseases such as HIV and influenza favor the growth in the recombinant vaccine market. However, there are some challenges that are being faced by recombinant vaccines market such as making recombinant vaccine which need to be cost effective and should have appropriate shelf life. Recombinant Vaccine Market Overview

3 © Coherent market Insights. All Rights Reserved The global recombinant vaccine market is segmented on the basis of type, disease type and region On the basis of type, Subunit Vaccines DNA vaccines Edible Vaccines Others Attenuated Recombinant Vaccine Vector recombinant vaccines On the basis of disease type the recombinant vaccine market is segmented into Hepatitis B Human Papillomaviruses (HPVs) Others Request Report Sample@ https://www.coherentmarketinsights.com/insight/request-sample/455 https://www.coherentmarketinsights.com/insight/request-sample/455 REPORT DESCRIPTION

4 © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION Continuous investments in research and developments for the recombinant vaccine field in North America region by industries The regional segmentation of recombinant vaccines market by Coherent Market Insights comprises North America, Asia Pacific, Africa, Europe, Latin America, and Middle East.. Europe is dominating in the regional segment of recombinant animal vaccines segments, as the highly organized livestock and the huge demand for livestock product for the European population. The increasing zoonotic diseases, continuous research and developments investments for the development of new and effective vaccines in the North America region is helping the recombinant vaccine market to grow in this region. As there is increasing number of people adopting the pets and there increasing awareness and responsibility for animals is helping to fasten the growth of the animal recombinant vaccine market in the Asia Pacific region. Key players operating the global recombinant vaccine market include Novartis AG, GlaxoSmithKline PLC, Green Cross Corporation, Protein Science Corporation, Sanofi Aventis, Merck, Pfizer, Bayer and Virba. Request For TOC@ https://www.coherentmarketinsights.com/ongoing- insight/toc/455https://www.coherentmarketinsights.com/ongoing- insight/toc/455

5 © Coherent market Insights. All Rights Reserved Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. ABOUT US ABOUT COHERENT MARKET INSIGHTS SERVICES INDUSTRY ANALYSIS CUSTOMIZED RESEARCH SYNDICATED RESEARCH CONSULT STUDIES MARKET INTELLIGENCE SERVICES COUNTRY SPECIFIC STUDIES

6 © Coherent market Insights. All Rights Reserved  Global Leading Equipment and System Manufacturers  Component Providers and System Integrators  Distributors, Retailors and Value Added Resellers  Healthcare IT Solutions Developers  Marketing Consultancies and the Advertising Industry  Private and Government organization  Outsourcing Companies  Universities and Business Schools. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGYCLINICAL DIAGNOSTICHEALTHCARE IT PHARMACEUTICALMEDICAL IMAGINGMEDICAL DEVICES OUR CLIENTS

7 © Coherent market Insights. All Rights Reserved Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. ABOUT US RESEARCH SOLUTIONS GLOBAL REPORTS FEASIBILITY STUDIES TECHNOLOGY SNIPPETS EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT SURVEY RESEARCH CUSTOMIZED SOLUTIONS CONSULT PROJECTS COUNTRY ANALYSIS KEY STATS Insights Published Per Year Consulting Projects Till Date Clients Worldwide Per Year Analysts and Contract Consultants 100+ 150+ 125+ 110+

8 © Coherent market Insights. All Rights Reserved THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702


Download ppt "© Coherent market Insights. All Rights Reserved RECOMBINANT VACCINE MARKET Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis,"

Similar presentations


Ads by Google